Dr. Parent is an Associate Professor in the UCSF Diabetes Center. Her research is focused on understanding changes in immune tolerance that lead to autoimmune destruction of pancreatic insulin-producing beta cells in type 1 diabetes (T1D). Her lab is combining directed differentiation of human pluripotent stem cells into cell types relevant to T1D with genome engineering approaches to model the human disease. They are also developing strategies to produce immune evasive stem cell-derived pancreatic beta cells to accelerate clinical translation of beta cell replacement therapies to treat diabetes.